Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Mol Pharm ; 9(1): 135-43, 2012 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-22118658

RESUMEN

Polymeric micelles formed by the self-assembly of amphiphilic block copolymers can be used to encapsulate hydrophobic drugs for tumor-delivery applications. Filamentous carriers with high aspect ratios offer potential advantages over spherical carriers, including prolonged circulation times. In this work, mixed micelles composed of poly(ethylene oxide)-poly[(R)-3-hydroxybutyrate]-poly(ethylene oxide) (PEO-PHB-PEO) and Pluronic F-127 (PF-127) were used to encapsulate a near-infrared fluorophore. The micelle formulations were assessed for tumor accumulation after tail vein injection to xenograft tumor-bearing mice by noninvasive optical imaging. The mixed micelle formulation that facilitated the highest tumor accumulation was shown by cryo-electron microscopy to be filamentous in structure compared to spherical structures of pure PF-127 micelles. In addition, increased dye loading efficiency and dye stability were attained in this mixed micelle formulation compared to pure PEO-PHB-PEO micelles. Therefore, the optimized PEO-PHB-PEO/PF-127 mixed micelle formulation offers advantages for cancer delivery over micelles formed from the individual copolymer components.


Asunto(s)
Medios de Contraste/administración & dosificación , Portadores de Fármacos/administración & dosificación , Verde de Indocianina/administración & dosificación , Melanoma Experimental/diagnóstico , Poloxámero/química , Polietilenglicoles/química , Animales , Fenómenos Químicos , Medios de Contraste/análisis , Medios de Contraste/farmacocinética , Portadores de Fármacos/análisis , Portadores de Fármacos/farmacocinética , Composición de Medicamentos , Estabilidad de Medicamentos , Humanos , Verde de Indocianina/análisis , Verde de Indocianina/farmacocinética , Inyecciones Intravenosas , Masculino , Melanoma Experimental/metabolismo , Melanoma Experimental/patología , Ratones , Ratones Endogámicos BALB C , Micelas , Prohibitinas , Organismos Libres de Patógenos Específicos , Espectroscopía Infrarroja Corta , Distribución Tisular , Imagen de Cuerpo Entero
2.
Pharm Res ; 27(9): 1900-13, 2010 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20568000

RESUMEN

PURPOSE: Indocyanine green (ICG), an FDA-approved near infrared (NIR) dye, has potential application as a contrast agent for tumor detection. Because ICG binds strongly to plasma proteins and exhibits aqueous, photo, and thermal instability, its current applications are largely limited to monitoring blood flow. To address these issues, ICG was encapsulated and stabilized within polymeric micelles formed from the thermo-sensitive block copolymer Pluronic F-127, poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide), to increase the stability and circulation time of ICG. METHODS: ICG-loaded Pluronic micelles were prepared at various concentrations of Pluronic and ICG and characterized by determining particle sizes, dye loading efficiency, and the kinetics of dye degradation. Förster resonance energy transfer spectroscopy was employed to monitor the stability of Pluronic micelles in physiological solutions. The plasma clearance kinetics and biodistribution of ICG-loaded micelles was also determined after intravenous delivery to CT-26 colon carcinoma tumor-bearing mice, and NIR whole-body imaging was performed for tumor detection. RESULTS: The Pluronic F-127 micelles showed efficient ICG loading, small size, stabilized ICG fluorescence, and prolonged circulation in vivo. Solid tumors in mice were specifically visualized after intravenous administration of ICG-loaded micelles. CONCLUSIONS: These materials are therefore promising formulations for noninvasive NIR tumor imaging applications.


Asunto(s)
Medios de Contraste/química , Portadores de Fármacos/química , Verde de Indocianina/química , Neoplasias/diagnóstico , Poloxámero/química , Espectroscopía Infrarroja Corta/métodos , Animales , Medios de Contraste/farmacocinética , Proteínas de Drosophila , Estabilidad de Medicamentos , Femenino , Transferencia Resonante de Energía de Fluorescencia , Verde de Indocianina/farmacocinética , Tasa de Depuración Metabólica , Ratones , Ratones Endogámicos BALB C , Micelas , Tamaño de la Partícula , Temperatura
3.
Biomaterials ; 35(31): 8895-8902, 2014 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-25064804

RESUMEN

Components of the blood have been proposed as potential therapeutic targets for improving cellular regeneration after injury and neurodegenerative disease. In this work, thrombin is shown to increase endogenous neural progenitor proliferation in the intact murine spinal cord. A local injection of heparin before a spinal cord injury reduces cell proliferation and astrogliogenesis associated with scarring. We sought to create depot-formulations of PLGA microsphere and Pluronic F-127 for sustained local delivery of two thrombin inhibitors, heparin and hirudin. Each hydrogel depot-formulation showed delayed drug release compared to microspheres or hydrogel alone. Animals with a lateral demyelination lesion showed a reduction in CD68+ macrophages when treated with hirudin-loaded PLGA/F-127 gels compared to control and heparin-treated animals. Moreover, hirudin-loaded materials showed an accelerated recovery in coordinated stepping and increased oligodendrocyte densities. Together, these data demonstrate that controlled delivery of hirudin accelerates functional recovery from a demyelination lesion in the spinal cord.


Asunto(s)
Antitrombinas/administración & dosificación , Preparaciones de Acción Retardada/química , Enfermedades Desmielinizantes/tratamiento farmacológico , Hirudinas/administración & dosificación , Ácido Láctico/química , Poloxámero/química , Ácido Poliglicólico/química , Traumatismos de la Médula Espinal/tratamiento farmacológico , Animales , Antitrombinas/uso terapéutico , Enfermedades Desmielinizantes/patología , Enfermedades Desmielinizantes/fisiopatología , Fibrinolíticos/administración & dosificación , Fibrinolíticos/uso terapéutico , Heparina/administración & dosificación , Heparina/uso terapéutico , Terapia con Hirudina , Ratones , Microesferas , Copolímero de Ácido Poliláctico-Ácido Poliglicólico , Recuperación de la Función/efectos de los fármacos , Médula Espinal/efectos de los fármacos , Médula Espinal/patología , Médula Espinal/fisiopatología , Traumatismos de la Médula Espinal/patología , Traumatismos de la Médula Espinal/fisiopatología
4.
Biomaterials ; 34(18): 4501-9, 2013 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-23498892

RESUMEN

Polymeric micelles are promising carriers for anti-cancer agents due to their small size, ease of assembly, and versatility for functionalization. A current challenge in the use of polymeric micelles is the sensitive balance that must be achieved between stability during prolonged blood circulation and release of active drug at the tumor site. Stimuli-responsive materials provide a mechanism for triggered drug release in the acidic tumor and intracellular microenvironments. In this work, we synthesized a series of dual pH- and temperature-responsive block copolymers containing a poly(ε-caprolactone) (PCL) hydrophobic block with a poly(triethylene glycol) block that were copolymerized with an amino acid-functionalized monomer. The block copolymers formed micellar structures in aqueous solutions. An optimized polymer that was functionalized with 6-aminocaproic acid (ACA) possessed pH-sensitive phase transitions at mildly acidic pH and body temperature. Doxorubicin-loaded micelles formed from these polymers were stable at blood pH (~7.4) and showed increased drug release at acidic pH. In addition, these micelles displayed more potent anti-cancer activity than free doxorubicin when tested in a tumor xenograft model in mice.


Asunto(s)
Portadores de Fármacos/química , Sistemas de Liberación de Medicamentos , Nanopartículas/química , Neoplasias/tratamiento farmacológico , Polímeros/síntesis química , Temperatura , Ácido Aminocaproico/síntesis química , Ácido Aminocaproico/química , Animales , Línea Celular Tumoral , Doxorrubicina/administración & dosificación , Doxorrubicina/farmacología , Doxorrubicina/uso terapéutico , Humanos , Concentración de Iones de Hidrógeno , Concentración 50 Inhibidora , Inyecciones , Cinética , Luz , Masculino , Ratones , Ratones Desnudos , Micelas , Nanopartículas/ultraestructura , Neoplasias/patología , Tamaño de la Partícula , Poliésteres/síntesis química , Poliésteres/química , Polietilenglicoles/síntesis química , Polietilenglicoles/química , Polímeros/química , Dispersión de Radiación , Ensayos Antitumor por Modelo de Xenoinjerto
5.
Biomaterials ; 31(28): 7386-97, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-20598741

RESUMEN

Doxorubicin (DOX) is an effective chemotherapeutic against a wide range of solid tumors. However, its clinical use is limited by severe side effects such as cardiotoxicity as well as inherent and acquired drug resistance of tumors. DOX encapsulation within self-assembled polymeric micelles has the potential to decrease the systemic distribution of free drug and enhance the drug accumulation in the tumor via the enhanced permeability and retention (EPR). In this study, DOX was encapsulated in micelles composed of poly (ethylene oxide)-poly [(R)-3-hydroxybutyrate]-poly (ethylene oxide) (PEO-PHB-PEO) triblock copolymers. Micelle size, DOX loading and DOX release were characterized. To evaluate DOX activity, micelles were tested in both monolayer cell cultures and three-dimensional (3-D) multicellular spheroids (MCS) that mimic solid tumors. Antitumor activity in vivo was further studied with tumor-bearing mice. The micelles improved the efficiency of Dox penetration in 3-D MCS compared with free DOX. Efficient cell killing by Dox-micelles in both monolayer cells and 3-D MCS was also demonstrated. Finally, DOX-loaded micelles mediate efficient tumor delivery from tail vein injections to tumor-bearing mice with much less toxicity compared with free DOX.


Asunto(s)
Antibióticos Antineoplásicos , Doxorrubicina , Micelas , Polietilenglicoles/química , Polímeros/química , Esferoides Celulares/efectos de los fármacos , Trasplante Heterólogo , Animales , Antibióticos Antineoplásicos/química , Antibióticos Antineoplásicos/metabolismo , Antibióticos Antineoplásicos/farmacología , Apoptosis , Materiales Biocompatibles/química , Materiales Biocompatibles/metabolismo , Línea Celular , Línea Celular Tumoral , Doxorrubicina/química , Doxorrubicina/metabolismo , Doxorrubicina/farmacología , Composición de Medicamentos , Sistemas de Liberación de Medicamentos , Humanos , Masculino , Ensayo de Materiales , Ratones , Ratones Desnudos , Estructura Molecular , Polietilenglicoles/metabolismo , Polímeros/metabolismo , Prohibitinas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA